Life expectancy in the United States has risen dramatically over the past century, yet recent data reveal a slowdown and even modest declines in certain groups. Understanding the forces behind these patterns helps policymakers, clinicians, and individuals make informed decisions about health investments and personal habits.
Historical Overview of US Life Expectancy
At the turn of the twentieth century the average American could expect to live roughly forty‑seven years. By 1950 that figure climbed to about sixty‑eight years, driven by reductions in infectious disease mortality, improvements in sanitation, and the advent of antibiotics. The latter half of the century saw steady gains, reaching a peak of seventy‑nine years in 2014 according to CDC vital statistics. Since then the trajectory has flattened, with the most recent estimates hovering near seventy‑seven years, reflecting a complex mix of medical progress and emerging threats.
Key Drivers of Recent Gains and Stalls
Medical breakthroughs in cardiovascular care, cancer screening, and vaccine development continue to add years for many adults. However, gains are offset by rising deaths from drug overdoses, alcohol‑related liver disease, and suicide, especially among middle‑aged whites. The opioid epidemic alone accounted for an estimated 0.3‑year reduction in overall life expectancy between 2014 and 2017. Simultaneously, progress against heart disease has slowed as obesity and diabetes prevalence climb.
Disparities by Race, Gender, and Geography
Life expectancy varies markedly across demographic lines. In 2022 non‑Hispanic Black men averaged about seventy‑one years, while non‑Hispanic White women reached roughly eighty‑one years. Hispanic populations often exhibit a paradoxical advantage, living longer than non‑Hispanic Whites despite lower socioeconomic status. Geographic gaps are equally stark: residents of Mississippi and West Virginia trail those in Hawaii and California by more than five years. These differences reflect unequal access to quality healthcare, education, and healthy environments.
Impact of Chronic Diseases and Opioid Crisis
Chronic conditions such as heart disease, cancer, chronic lower respiratory disease, and diabetes remain the leading causes of death. The opioid crisis has added a distinct mortality layer, disproportionately affecting adults aged twenty‑five to fifty‑four. Public health responses — expanding medication‑assisted treatment, improving prescription monitoring, and increasing naloxone distribution — have begun to curb overdose deaths, but the long‑term effect on life expectancy will depend on sustained funding and stigma reduction.
Role of Healthcare Access and Policy
Insurance coverage expansions under the Affordable Care Act contributed to modest life expectancy improvements between 2010 and 2016, particularly for low‑income adults. States that adopted Medicaid expansion saw larger reductions in mortality from treatable conditions. Conversely, coverage gaps, high out‑of‑pocket costs, and provider shortages in rural areas continue to limit preventive care utilization, preserving disparities.
Socioeconomic Factors and Education
Education level is one of the strongest predictors of longevity. Adults with a bachelor’s degree live on average six to nine years longer than those without a high school diploma. Income inequality, food insecurity, and unstable housing compound health risks. Community‑level interventions — such as living‑wage policies, affordable housing initiatives, and school‑based nutrition programs — have demonstrated measurable impacts on mortality rates in pilot studies.
Emerging Trends: COVID‑19 and Long‑Term Effects
The COVID‑19 pandemic caused a historic drop of roughly one and a half years in US life expectancy between 2019 and 2021, the largest single‑year decline since World War II. While vaccines and treatments have restored much of the loss, excess mortality persists from delayed care, long COVID, and mental health strain. Ongoing surveillance of post‑acute sequelae will be essential for accurate forecasting.
Actionable Steps for Individuals and Communities
Individuals can improve personal odds by maintaining a balanced diet, engaging in regular physical activity, avoiding tobacco, limiting alcohol, and staying current on recommended screenings and vaccinations. Communities benefit from investing in walkable neighborhoods, accessible primary care, and robust substance‑use treatment networks. Employers can support wellness through flexible schedules, mental‑health resources, and health‑literacy programs. Policymakers should prioritize universal coverage, funding for preventive services, and data‑driven equity initiatives.
Measuring Life Expectancy: Methods, Period vs Cohort, and Data Quality
Life expectancy figures quoted in the media are usually period life expectancy at birth, a synthetic measure that applies the age‑specific death rates observed in a single calendar year to a hypothetical cohort. This approach is useful for tracking short‑term shifts such as the COVID‑19 shock, but it can mislead when mortality conditions are changing rapidly. Cohort life expectancy, by contrast, follows an actual birth cohort through time and requires longitudinal mortality data that are only available for older generations. Researchers therefore rely on hybrid methods — such as the Lee‑Carter model or Bayesian hierarchical forecasting — to blend period and cohort information and produce more stable long‑term projections. Data quality matters immensely: vital‑statistics registration completeness varies by state, and misclassification of race or ethnicity on death certificates can bias subgroup estimates by several months. The National Center for Health Statistics conducts periodic linkage studies with the Census Bureau to quantify these errors, and analysts should always report confidence intervals that incorporate both sampling variability and registration uncertainty.
Practical analysts often compute life expectancy at multiple ages (e.g., 65, 75) to inform retirement planning and long‑term care financing. When comparing subpopulations, age‑standardization using the 2000 U.S. standard population eliminates distortion from differing age structures. Edge cases arise in small geographic units — counties with fewer than 1,000 residents — where stochastic fluctuations dominate; here, Bayesian smoothing or multi‑year pooling (typically three‑year rolling averages) is essential before any policy interpretation. Finally, the choice of life‑table construction (complete vs abridged) influences the granularity of results: complete tables use single‑year age intervals and are preferred for high‑precision work, while abridged tables (five‑year intervals) suffice for most public‑health dashboards.
Environmental and Climate Determinants of Longevity
Ambient air pollution, temperature extremes, and exposure to hazardous waste sites have measurable effects on mortality that are not fully captured by traditional behavioral risk factors. Long‑term cohort studies such as the American Cancer Society Cancer Prevention Study II have shown that each 10 µg/m³ increase in fine particulate matter (PM2.5) is associated with a 0.5‑year reduction in life expectancy at age 30, after adjusting for smoking, socioeconomic status, and occupational exposures. Heat waves pose acute risks, especially for older adults with cardiovascular disease; the 2021 Pacific Northwest heat dome produced an estimated 600 excess deaths in a single week, a signal that climate‑attributable mortality is becoming a routine component of vital‑statistics analysis. Conversely, access to green space and tree canopy has been linked to modest gains — roughly 0.2‑0.3 years — through pathways that include increased physical activity, reduced stress, and improved air filtration.
Policy relevance emerges when environmental justice screens are overlaid on life‑expectancy maps. Communities adjacent to former industrial corridors (e.g., the Ohio River Valley, parts of the Gulf Coast) consistently show life‑expectancy deficits of 2‑4 years relative to demographically similar neighborhoods without such legacy contamination. Mitigation strategies — stricter EPA emission standards, superfund remediation timelines, urban forestry programs — have demonstrated measurable mortality reductions in quasi‑experimental designs. For instance, the 1990 Clean Air Act Amendments are credited with averting an estimated 160,000 premature deaths annually by 2020, translating into a population‑level life‑expectancy gain of about 0.4 years. Edge cases include rural areas where monitoring stations are sparse; satellite‑derived aerosol optical depth combined with ground‑based calibration now enables exposure estimation at 1 km resolution, allowing researchers to fill gaps in the traditional monitoring network.
Mental Health, Suicide, and Behavioral Health Trends
While the opioid crisis receives extensive coverage, rising suicide rates and the growing burden of mood and anxiety disorders constitute a parallel mortality driver that disproportionately affects middle‑aged men, veterans, and sexual‑minority populations. Age‑adjusted suicide mortality climbed from 10.5 per 100,000 in 1999 to 14.2 per 100,000 in 2022, erasing roughly 0.2 years of life expectancy at the national level. The increase is not uniform: rural counties with limited mental‑health provider density (fewer than 1 psychiatrist per 30,000 residents) exhibit rates up to twice the national average. Firearm access amplifies lethality; states with higher household gun ownership show steeper suicide curves even after controlling for depression prevalence.
Integrated behavioral‑health models — co‑locating primary care, psychiatry, and peer‑support services — have reduced emergency‑department visits for self‑harm by 25 % in pilot sites across Colorado and New Mexico. Digital interventions, such as smartphone‑based cognitive‑behavioral therapy (CBT) platforms, show promise for scaling evidence‑based treatment, yet adherence drops sharply after the first month without human coaching. An emerging edge case is the interaction between long COVID neuropsychiatric sequelae and pre‑existing vulnerability; early registry data suggest a 1.5‑fold increase in new‑onset depressive episodes among previously healthy adults, potentially feeding future suicide risk. Policymakers should consider mandatory suicide‑risk screening in primary‑care visits, universal background‑check expansions, and sustained funding for the 988 Suicide and Crisis Lifeline to translate these findings into population‑level gains.
Maternal, Infant, and Child Health Contributions to Population Longevity
Improvements in early‑life survival have historically driven large shares of life‑expectancy gains, yet recent stagnation in infant mortality (5.4 deaths per 1,000 live births in 2022, unchanged since 2015) signals a plateau that drags down the overall metric. Racial disparities remain stark: non‑Hispanic Black infants experience a mortality rate more than double that of non‑Hispanic White infants, a gap that persists after adjusting for maternal education and prenatal care timing. Maternal mortality, though low in absolute terms, rose from 17.4 per 100,000 live births in 2018 to 32.9 in 2021, driven by cardiovascular conditions, hemorrhage, and sepsis — many of which are preventable with standardized obstetric safety bundles.
Investments in perinatal regionalization — ensuring that high‑risk deliveries occur in Level III/IV neonatal intensive care units — have reduced neonatal mortality by up to 15 % in states that adopted formal transport protocols. Home‑visiting programs (e.g., Nurse‑Family Partnership) yield a 0.1‑year life‑expectancy gain per participant cohort by improving birth weight, breastfeeding rates, and subsequent childhood immunization compliance. Edge cases include undocumented immigrant families who avoid prenatal care due to fear of enforcement; community‑health‑worker outreach combined with fire‑wall policies (no data sharing with immigration authorities) has restored utilization rates to near‑national averages in several California counties. Long‑term, reducing preterm birth (<37 weeks) from the current 10.5 % to the Healthy People 2030 target of 9.4 % would add an estimated 0.15 years to national life expectancy, underscoring the outsized leverage of early‑life interventions.
Technology, Data Analytics, and Precision Public Health
The convergence of electronic health records (EHR), wearable sensors, and population‑level genomic data is reshaping how mortality risk is identified and mitigated. Predictive algorithms trained on claims data can flag individuals at high 5‑year risk of cardiovascular death with an area under the curve exceeding 0.85, enabling targeted lipid‑lowering therapy and lifestyle coaching. In the Veterans Health Administration, a machine‑learning model that integrates lab trends, medication adherence, and social‑determinant flags reduced 30‑day readmission for heart failure by 12 %, a proxy for mortality reduction. However, algorithmic bias remains a concern: models trained predominantly on White, insured populations under‑estimate risk for Black and Hispanic patients, potentially widening disparities if deployed without recalibration.
Real‑time syndromic surveillance — leveraging emergency‑department chief‑complaint feeds, over‑the‑counter medication sales, and school absenteeism — allowed several states to detect the 2022‑2023 RSV surge two weeks earlier than traditional laboratory reporting, prompting timely prophylaxis campaigns for high‑risk infants. Wearable‑derived heart‑rate variability and sleep metrics have been validated as early markers of frailty progression in community‑dwelling elders; a randomized trial showed that a 6‑month digital coaching program based on these metrics improved gait speed and reduced 1‑year mortality by 8 % relative to usual care. Edge cases involve data‑governance frameworks: consent models for continuous sensor streams, interoperability standards (FHIR), and equitable broadband access are prerequisites for scaling precision public health beyond academic medical centers. Policymakers should incentivize open‑source algorithm repositories, mandate bias audits, and fund community‑based digital navigators to ensure that technological gains translate into broader life‑expectancy improvements.
Future Projections and Scenario Modeling for US Longevity
Forecasting life expectancy beyond the next decade requires explicit scenario building rather than simple extrapolation. The Social Security Administration’s intermediate‑cost assumption projects a modest rise to 80.5 years by 2060, but alternative pathways diverge sharply. A “health‑technology acceleration” scenario — assuming widespread adoption of senolytic therapies, AI‑guided early cancer detection, and universal genomic screening — could push cohort life expectancy at birth to 85‑87 years for children born in 2030. Conversely, a “climate‑stress” scenario incorporating projected heat‑related mortality, vector‑borne disease expansion, and food‑system disruptions yields a plateau near 78 years, with widening geographic gaps.
Key leverage points identified through microsimulation (e.g., the Future Elderly Model) include: (1) reducing adult obesity prevalence from 42 % to 30 % — yields +0.7 years; (2) achieving 90 % medication‑assisted treatment coverage for opioid use disorder — yields +0.3 years; (3) eliminating racial mortality gaps in cardiovascular disease — yields +0.5 years. Sensitivity analyses reveal that outcomes are most responsive to assumptions about future smoking prevalence and the pace of medical‑innovation diffusion. Edge cases involve demographic composition shifts: the growing share of foreign‑born residents, who currently enjoy a 2‑year life‑expectancy advantage, will alter national averages if immigration policy changes. Robust policy planning therefore demands probabilistic forecasting ensembles, transparent assumption documentation, and regular updating as new mortality data — especially post‑pandemic excess‑death revisions — become available.
Social Isolation, Loneliness, and Community Cohesion as Mortality Risk Factors
Research over the past two decades has established that chronic loneliness carries a mortality risk comparable to smoking fifteen cigarettes per day. Meta‑analyses of prospective cohort studies show a 26 % increase in all‑cause death for adults reporting persistent social isolation, after adjusting for baseline health, socioeconomic status, and health behaviors. The effect is strongest among adults aged sixty‑five and older, where loss of a spouse, retirement, and reduced mobility converge to shrink social networks.
Community‑level interventions have demonstrated measurable gains. The “Village” model, pioneered in Boston and replicated in dozens of cities, organizes neighbor‑to‑neighbor assistance for transportation, grocery shopping, and technology help. Evaluations report a 12 % reduction in emergency‑department visits and a modest 0.15‑year increase in life expectancy at age seventy for participants. Similar outcomes appear in the “Men’s Sheds” movement, which provides shared workshop space for older men to build social ties while learning skills; pilot data from Australia and the United Kingdom show a 9 % decline in depressive symptoms and a 0.1‑year longevity gain.
Edge cases arise in high‑density urban neighborhoods where physical proximity does not guarantee meaningful contact. Digital platforms can supplement but not replace face‑to‑face interaction; randomized trials of video‑call programs for homebound seniors show initial engagement drops sharply after three months without a human facilitator. Policymakers should therefore fund hybrid models that combine community health workers, volunteer coordinators, and low‑cost technology, while measuring social‑network density as a core public‑health indicator.
Integrating loneliness screening into primary‑care visits — using the three‑item UCLA Loneliness Scale — enables early referral to community resources. Reimbursement codes for “social‑prescribing” are emerging in several state Medicaid programs, creating a financial pathway for clinicians to prescribe group exercise classes, art workshops, or peer‑support groups. When scaled, these approaches can shift the population‑level mortality curve by addressing a risk factor that is largely invisible in traditional vital‑statistics reporting.
Occupational Health, Workplace Exposures, and the Changing Nature of Work
The transition from manufacturing to service and gig economies has reshaped the profile of occupational mortality. While fatal injuries have declined overall, non‑fatal exposures — repetitive‑motion disorders, psychosocial stress, and irregular shift schedules — now account for a larger share of premature death. Long‑hour workweeks (>55 hours) are linked to a 35 % higher risk of ischemic heart disease and a 17 % higher risk of stroke, according to a 2021 WHO‑ILO joint estimate. Gig workers, lacking employer‑sponsored health insurance and workers’ compensation, experience a 1.4‑fold increase in mortality from cardiovascular causes compared with traditional employees.
Emerging hazards include algorithmic management and pervasive monitoring, which elevate cortisol levels and reduce autonomy. A 2023 study of warehouse workers found that real‑time productivity tracking increased systolic blood pressure by an average of 8 mmHg during shifts. Conversely, workplaces that adopt participatory ergonomics — allowing employees to redesign tasks — report a 22 % reduction in musculoskeletal claims and a measurable improvement in heart‑rate variability, a biomarker of autonomic health.
Edge cases involve workers with multiple part‑time jobs who fall through regulatory cracks. The “joint employer” doctrine remains unsettled, leaving many without access to occupational‑health surveillance. Portable benefits platforms, currently piloted in Washington and California, aim to attach health‑savings accounts, paid‑sick leave, and disability insurance to the worker rather than the employer. Early enrollment data suggest a 7 % increase in preventive‑care utilization among enrolled gig drivers.
Policy levers include expanding OSHA’s General Duty Clause to cover psychosocial hazards, mandating rest‑break standards for algorithmically managed work, and incentivizing employers to adopt total‑worker‑health frameworks that integrate safety, wellness, and chronic‑disease management. When combined with universal health coverage, these measures can translate occupational‑health gains into population‑level life‑expectancy improvements.
Housing Quality, Environmental Hazards in the Home, and Residential Segregation
Substandard housing — lead paint, mold, inadequate heating, and pest infestations — exerts a direct, quantifiable toll on longevity. Children living in homes with blood‑lead levels above 5 µg/dL lose an estimated 0.3 years of life expectancy by age thirty, primarily through neurodevelopmental deficits that cascade into lower educational attainment and higher adult mortality. Adults exposed to chronic dampness and mold have a 1.5‑fold increase in respiratory‑related hospitalizations, which translates into a 0.2‑year reduction in life expectancy at age fifty.
Residential segregation amplifies these risks. Historical redlining maps align closely with present‑day clusters of poor housing stock, limited green space, and higher ambient pollution. A 2022 analysis of 150 metropolitan areas found that neighborhoods graded “D” by the Home Owners’ Loan Corporation in the 1930s now exhibit life‑expectancy deficits of 3‑5 years relative to “A”‑graded areas, even after controlling for income and race. The mechanism operates through cumulative exposure to multiple hazards and reduced access to health‑promoting resources.
Edge cases include “energy‑poverty” households that cannot afford adequate heating or cooling, leading to excess winter mortality and heat‑related deaths. The Low‑Income Home Energy Assistance Program (LIHEAP) reduces winter mortality by an estimated 1.5 % in participating counties, but funding shortfalls leave 30 % of eligible households unserved. Similarly, lead‑service‑line replacement programs have achieved 90 % coverage in some cities, yet renters in older multifamily buildings often lack the authority to compel landlords to act.
Effective interventions combine code enforcement, targeted subsidies for remediation, and community‑land‑trust models that preserve affordable, high‑quality housing. Cities such as Rochester, New York, have linked rental‑license renewal to lead‑safe certification, resulting in a 40 % drop in childhood lead poisoning over five years. Integrating housing‑quality metrics into community health needs assessments ensures that housing policy is treated as a core determinant of longevity.
Early‑Life Adversity, Adverse Childhood Experiences, and Lifelong Mortality Trajectories
The Adverse Childhood Experiences (ACE) study established a dose‑response relationship between childhood trauma and adult mortality. Individuals with four or more ACEs have a 2.2‑fold higher risk of premature death before age sixty‑five, driven by cardiovascular disease, cancer, and suicide. The biological embedding of stress — via dysregulated hypothalamic‑pituitary‑adrenal axis, epigenetic modifications, and chronic inflammation — creates a physiological substrate that persists across the lifespan.
Intergenerational transmission magnifies the effect. Parents with high ACE scores are more likely to experience housing instability, substance use, and mental‑health crises, which in turn elevate ACE exposure for their children. Home‑visiting programs such as Nurse‑Family Partnership break this cycle; randomized trials show a 0.12‑year gain in life expectancy for the offspring cohort at age forty, mediated by improved birth weight, higher immunization rates, and reduced child‑protective‑services involvement.
Edge cases involve children in foster care and juvenile‑justice systems, where ACE scores often exceed six. Trauma‑informed care models that integrate mental‑health services, educational continuity, and stable caregiving relationships reduce all‑cause mortality by 18 % in longitudinal follow‑up. However, funding streams remain fragmented across child‑welfare, Medicaid, and education agencies, limiting scale.
Policy opportunities include universal ACE screening at well‑child visits, mandated trauma‑informed training for teachers and clinicians, and sustained investment in two‑generation programs that address parental and child needs simultaneously. By targeting the root causes of early adversity, the health system can shift the entire mortality curve upward, yielding gains that compound across generations.
Health System Fragmentation, Care Coordination, and the Role of Primary Care Continuity
Despite high per‑capita spending, the United States exhibits pronounced fragmentation: patients average 4.5 distinct clinicians per year, and 30 % of Medicare beneficiaries experience a care‑transition error within thirty days of hospital discharge. Discontinuity is linked to a 15 % increase in preventable hospitalizations and a measurable reduction in life expectancy, especially for adults with multiple chronic conditions. Continuity of primary care — measured by the Usual Provider Continuity index — correlates with a 0.3‑year longevity advantage at age sixty‑five.
Accountable Care Organizations (ACOs) and patient‑centered medical homes aim to restore coordination, yet results vary. ACOs that embed community health workers, pharmacists, and behavioral‑health specialists within the primary‑care team achieve a 9 % reduction in 30‑day readmissions and a 0.15‑year gain in life expectancy for attributed populations. In contrast, ACOs that rely solely on claims‑based risk adjustment without team‑based care show negligible mortality impact.
Edge cases arise for patients with limited English proficiency, low health literacy, or unstable housing, who are least likely to benefit from digital portals or telehealth follow‑up. “Navigation” programs that assign a dedicated lay navigator to high‑risk patients improve appointment adherence by 27 % and reduce emergency‑department use by 19 %. However, reimbursement for navigator time remains inconsistent across payers.
System‑level reforms should incentivize longitudinal relationships — for example, by adjusting capitation payments for continuity metrics — and mandate interoperable care‑plan sharing across settings. Standardized transition‑of‑care summaries, real‑time admission‑discharge‑transfer alerts, and shared medication‑reconciliation platforms can close the gaps that currently erode the mortality benefits of medical advances.
Incarceration, Criminal Justice Involvement, and Post‑Release Mortality Risks
Incarceration exerts a profound, lasting impact on life expectancy. Formerly incarcerated adults face a 12‑fold higher risk of death in the first two weeks after release, driven by drug overdose, cardiovascular events, and suicide. Over a lifetime, each year spent in prison reduces expected remaining life by approximately 0.5 years, even after controlling for pre‑incarceration health status. The United States’ incarceration rate — the highest among OECD nations — therefore constitutes a measurable drag on national longevity.
Health care within correctional facilities is constitutionally mandated but highly variable. Only 38 % of state prisons meet the National Commission on Correctional Health Care accreditation standards. Gaps in chronic‑disease management, mental‑health treatment, and substance‑use disorder care create a “health‑care cliff” at release. Medicaid’s “inmate exclusion” policy suspends coverage during incarceration, and re‑enrollment delays average 45 days, leaving a critical window without medication access.
Edge cases include individuals with serious mental illness who cycle between jail, emergency departments, and homelessness. “Stepping‑stone” programs that provide transitional housing, peer‑support specialists, and immediate Medicaid activation cut post‑release mortality by 30 % in pilot sites in New York and Massachusetts. Similarly, medication‑assisted treatment (MAT) initiation before release — combined with community‑based continuation — reduces overdose deaths by 75 % in the first month.
Policy levers include repealing the Medicaid inmate exclusion, mandating pre‑release care coordination, and investing in reentry health hubs that integrate primary care, behavioral health, and social services. States that have expanded Medicaid to cover justice‑involved populations report a 0.07‑year increase in overall life expectancy, demonstrating that addressing the health consequences of incarceration is both a moral imperative and a population‑health strategy.
Frequently Asked Questions
What is the current average life expectancy in the United States?
As of the latest CDC provisional data for 2023 the overall life expectancy at birth is approximately seventy‑seven years.
Why did life expectancy decline during the COVID‑19 pandemic?
The pandemic caused a surge in deaths from the virus itself and indirect effects such as delayed medical care, increased drug overdoses, and heightened mental‑health crises.
Which groups experience the lowest life expectancy?
Non‑Hispanic Black men, Native American populations, and residents of several Southern states consistently show the lowest averages.
How does education influence longevity?
Higher educational attainment correlates with better health literacy, higher income, safer occupations, and greater access to preventive care, all of which extend lifespan.
What policy measures have the strongest evidence for raising life expectancy?
Expanding Medicaid, increasing funding for community health centers, implementing comprehensive tobacco control, and investing in early childhood education have demonstrated the most consistent positive effects.
Related posts:
The Nonprofits Making Real Change in Wellness
Home Testing for Breast Cancer Risk
Meet the Woman Making Periods Safer for Everyone
Take Control of Your Digital Life Before Google Takes Control of You
New Study Shows U.S. Life Expectancy Dropped 1.5 Years in 2020—Here’s Why
UV Index Tracking with Apple Watch
78. BMMA’s Fight Against Maternal Mortality
Apple Watch Teams Up with Aetna for Health Innovation